Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive Lithium for Psychotic Mania in Adolescents
NCT01495156Phase 4Withdrawn
- Sponsor
- Northwell Health
- Start
- Sep 2011
- Primary completion
- Sep 2014
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in bipolar I disorder comparing Lithium/Adjunctive SGA with Placebo/Adjunctive SGA (2 arms). Primary endpoints: Time to partial or full response at 8 weeks and Time to recurrence of a subsyndromal mood episode at 24 weeks. Planned start Sep 2011; status: withdrawn.
02
Drugs
lithium
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT01495156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01495156.